News

Drugmaker Sarepta Therapeutics said late Friday it will not comply with a request from the Food and Drug Administration to ...
In a highly unusual move, Cambridge-based Sarepta said late Friday won’t comply with a request from the Food and Drug ...
Sarepta (SRPT) plans to continue Elevidys shipments for Duchenne muscular dystrophy, despite FDA request not to do so after ...
Analysts are intrested in these 5 stocks: ( ($JPM) ), ( ($SBUX) ), ( ($HPE) ), ( ($SRPT) ) and ( ($ELV) ). Here is a breakdown of their recent ...
MoffettNathanson analyst Michael Nathanson maintained a Buy rating on Netflix today and set a price target of $1,400.00. The company’s shares opened today at $1,241.96. Elevate ...
Evercore ISI analyst Mark Mahaney maintained a Buy rating on Netflix today and set a price target of $1,375.00. The company’s shares opened today at $1,241.96. Elevate Your Inve ...